Trademark: 97541148
Word
REXNESVY
Status
Pending
Status Code
730
Status Date
Monday, March 4, 2024
Serial Number
97541148
Mark Type
4000
Filing Date
Tuesday, August 9, 2022
Published for Opposition
Tuesday, July 11, 2023

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Mar 5, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 4, 2024
Sou Extension 1 Granted
Mar 4, 2024
Sou Extension 1 Filed
Mar 4, 2024
Sou Teas Extension Received
Sep 5, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 12, 2023
Teas Change Of Correspondence Received
Jul 12, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2023
Teas Change Of Owner Address Received
Jul 11, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 11, 2023
Published For Opposition
Jun 21, 2023
Notification Of Notice Of Publication E-Mailed
Jun 3, 2023
Approved For Pub - Principal Register
May 20, 2023
Examiner's Amendment Entered
May 20, 2023
Notification Of Examiners Amendment E-Mailed
May 20, 2023
Examiners Amendment E-Mailed
May 20, 2023
Examiners Amendment -Written
May 20, 2023
Assigned To Examiner
Aug 15, 2022
New Application Office Supplied Data Entered
Aug 12, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24